| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.089 | 0.06 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.07 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.07 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |